Long before modern medicine relied on sophisticated clinical trials, researchers faced a fundamental obstacle: human bias. People frequently felt better simply because they believed a treatment should work, while experimenters often allowed their own hopes to cloud their evaluations. Overcoming these natural tendencies required developing clever methods to isolate true cause and effect from mere perception.
Early Sham Tests and Benjamin Franklin's Interventions
According to the Science History Institute's account of early experimental controls, testing methods that concealed the truth were used to evaluate unusual claims long before the modern era. In 1599, a royal commission in France conducted a disguised trial to evaluate a woman claiming demon possession. By substituting ordinary water for holy water and reciting classical poetry instead of sacred texts, investigators observed that the subject still reacted with agony to the fake rituals, casting doubt on the supernatural claims.
By the late 18th century, similar blinded techniques were deployed against mesmerism, a form of hypnotism gaining popularity in Paris. To determine whether the phenomenon held genuine therapeutic value, the French Academy of Science assembled a commission that included statesman and inventor Benjamin Franklin. The commission designed trials comparing real mesmerists with sham practitioners while keeping the subjects blinded. The results demonstrated that sham mesmerism produced identical effects, revealing that the reported outcomes stemmed from belief rather than a mysterious force.
Refining the Gold Standard
As medical testing progressed into the 19th and 20th centuries, researchers systematically addressed subtle sources of error. Single-blind studies, where only the recipient remains unaware of the assignment, helped eliminate patient placebo effects. Later, double-blind designs ensured that the evaluators themselves remained unaware of who received the genuine treatment, eliminating subconscious bias in measuring outcomes.
Even assigning patients to groups proved vulnerable to subconscious manipulation. Early attempts at alternate allocation, such as giving every second patient the experimental cure, often failed because researchers found ways to alter the sequence. In the 1940s, statistician Austin Bradford Hill championed true randomization during streptomycin trials for pulmonary tuberculosis, introducing sealed envelopes derived from random numbers to assign control and treatment groups fairly.
The gradual development of these techniques reflects an insightful editorial lesson: rigorous scientific methodology is ultimately a series of tools designed to guard researchers against their own blind spots. By anticipating human bias, early scientific pioneers built the groundwork for modern medical evidence.
AI-generated editorial illustration; not a documentary photograph.
Source: Distillations podcast
The History of Clinical Trials: From Fake Exorcisms to Testing Today
SIGNAL TITANS
Leave a Reply